Blog / Archives
Illumina (ILMN $50.35) Good Value
CEO Jay Flatley was on CNBC at 4:55p today with Maria Bartiromo. Maria asked him why the Company did not accept the Roche offer? He answered " because the offer was near the stock's low for the...
Sell-Off Picks Up With Some Biotechs Hit Hard
Smaller Cap Biotechs In Major Correction All the major indices are down in the 1.75% range and now the NASDAQ at 2902 is 100 pts. away from the elusive 3000 level. Analysts have been warning about...
Caution Rules: Easy Money Has Been Made With Biotech Up 15% YTD
Pause Mode Since February 15 The biotech indices and ETF's we track are off about 1% or more today as the market is in a profit taking mode. The Rayno Life Science Portfoio is also off about 1%....
Biotech Bull Market Intact But Due For A Pause
Not A Good Time To Overweight Biotech Positions We are still in a holding pattern and recommend that caution be exercised regarding new positions. Although biotech stocks have made a nice run over...
Another Daily Reversal : Take More Off in Biotech
Have you read the book "Think Fast,Think Slow" by Daniel Kahneman? Well my System 1 (fast, intuitive and emotional) brain sees a lot of red on the screen telling me to take profits. If you want...
Gilead (GILD $46.50) off 15% on Hep-C Clinical Data -Viral Relapse Seen
$11B bet on Pharmasset acquisition for Hepatitus -C drug hits a snag Gilead announced that a majority (6/8) of the hepatitis C genotype-1 patients experienced a viral relapse when treated with...
No Panic Just Take A Little Off:Caution- Update Rally 2/16
Market Reversal and a Light Sell-Off Technicals and a market reversal particularly a $20+ drop in AAPL gives us reason to take profits or hedge after a great start to 2012. The S&P is up 7%...
Rayno Life Science Portfolio Racks-Up More Gains: REGN, RGDX, SRLS
Who Does Not Know About the Bull Market in Biotech Stocks? The bull market in life science stocks gathered momentum today as the IBB rallied 2.34% (up 16.6% YTD) approaching its all time high of...
Response Genetics Raises $7.5M at $1.50 with New CEO
Early Player in Genetic Testing and Personalized Medicine Reloads RGDX Stock Trades Up 36% on Volume of 105k Shares at $1.60 Response Genetics (RGDX) announced today that it has entered purchase...
Biopharma Market Re-Ignited by News and NASDAQ Strength
The IBB hit another new high today at $118.85 as the biotech bull market rolls on. Our index of biopharmaceutical stocks were up 4% at one time propelled by Medivation (MDVN $67.67) up 22% on...